LBEC0101
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for LBEC0101, covering 2011-02-18 to 2018-07-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrexate (MTX) [Phase 3]